Little evidence exists in the literature regarding the function of the protein encoded by IFI44L. However, it is important to mention that a related gene, IFI44, and IFIT1 were found to be among the genes that best predicted the response to IFNβ treatment in MS patients [19]. The gene discussed is IFI44; the disease is myeloid sarcoma.